Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFidelity Regulatory News (FSV)

Share Price Information for Fidelity (FSV)

Share Price is delayed by 15 minutes
Get Live Data
424.50    1.50 (0.35%)
Bid:
424.50
Ask:
426.00
Spread: 1.50 (0.353%)
Market Cap: £1.38b
FSV Live PriceLast checked at - London Stock Exchange

Intraday Fidelity Share Chart

Hardman&Co- Making a case study for outperformance

17 Mar 2023 14:45

RNS Number : 4127T
Fidelity Special Values PLC
17 March 2023
 

Hardman & Co Research on Fidelity Special Values Plc (FSV):

Making a case study for outperformance

 

With FSV having recently reached a decade of outperformance under fund manager Alex Wright's stewardship, we look at what has made this happen. We outline the investment process, and then provide a couple of detailed case studies to illustrate how it works in practice. The approach is essentially a contrarian one, using Fidelity's experienced team of analysts to look for unappreciated companies where there is a catalyst for change. This is underpinned by low valuations, which are used to provide downside protection, rather than being the source of outperformance that a conventional value approach might take.

 

Please click on the link below for the full report:

https://hardmanandco.com/research/corporate-research/making-a-case-study-for-outperformance/

If you are interested in meeting the company, you can register your interest by clicking on the above link.

 

To contact us:

Hardman & Co1 Frederick's Place

London

EC2R 8AE

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Brian Moretta+44 (0)203 693 7075

 

bm@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259. Attention is drawn to the important disclaimers at the end of the report.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJRMITMTTBBIJ
Date   Source Headline
8th Dec 20257:49 amRNSNet Asset Value(s)
5th Dec 20257:35 amRNSNet Asset Value(s)
4th Dec 20256:14 pmPRNPortfolio Update
4th Dec 20257:21 amRNSNet Asset Value(s)
3rd Dec 20257:30 amRNSNet Asset Value(s)
2nd Dec 202512:30 pmPRNDirectorate change
2nd Dec 20257:33 amRNSNet Asset Value(s)
1st Dec 20252:29 pmPRNTotal Voting Rights
1st Dec 20258:13 amRNSNet Asset Value(s)
28th Nov 20258:16 amRNSNet Asset Value(s)
27th Nov 20257:53 amRNSNet Asset Value(s)
26th Nov 20257:45 amRNSNet Asset Value(s)
25th Nov 20253:30 pmPRNMonthly Factsheet
25th Nov 20257:54 amRNSNet Asset Value(s)
24th Nov 20257:43 amRNSNet Asset Value(s)
21st Nov 20257:52 amRNSNet Asset Value(s)
20th Nov 20257:42 amRNSNet Asset Value(s)
19th Nov 20257:51 amRNSNet Asset Value(s)
18th Nov 20257:46 amRNSNet Asset Value(s)
17th Nov 20257:52 amRNSNet Asset Value(s)
14th Nov 20257:52 amRNSNet Asset Value(s)
13th Nov 20257:49 amRNSNet Asset Value(s)
12th Nov 20257:36 amRNSNet Asset Value(s)
11th Nov 20257:40 amRNSNet Asset Value(s)
10th Nov 20257:22 amRNSNet Asset Value(s)
7th Nov 20257:52 amRNSNet Asset Value(s)
6th Nov 20257:46 amRNSNet Asset Value(s)
6th Nov 20257:15 amPRNDividend Declaration
6th Nov 20257:00 amPRNAnnual Financial Report
5th Nov 20257:37 amRNSNet Asset Value(s)
4th Nov 20257:45 amRNSNet Asset Value(s)
3rd Nov 20254:15 pmPRNTotal Voting Rights
3rd Nov 20257:34 amRNSNet Asset Value(s)
31st Oct 20258:13 amRNSNet Asset Value(s)
30th Oct 20257:37 amRNSNet Asset Value(s)
29th Oct 20257:39 amRNSNet Asset Value(s)
28th Oct 20257:40 amRNSNet Asset Value(s)
27th Oct 20257:56 amRNSNet Asset Value(s)
24th Oct 20257:30 amRNSNet Asset Value(s)
23rd Oct 20259:23 amPRNMonthly Factsheet
23rd Oct 20257:30 amRNSNet Asset Value(s)
22nd Oct 20257:38 amRNSNet Asset Value(s)
21st Oct 20257:42 amRNSNet Asset Value(s)
20th Oct 20257:51 amRNSNet Asset Value(s)
17th Oct 20257:50 amRNSNet Asset Value(s)
16th Oct 20257:47 amRNSNet Asset Value(s)
15th Oct 20257:53 amRNSNet Asset Value(s)
14th Oct 20257:43 amRNSNet Asset Value(s)
13th Oct 20257:57 amRNSNet Asset Value(s)
10th Oct 20257:52 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.